Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts

Area of Science:

• Cardiovascular Physiology
• Electrophysiology
• Cardiac Arrhythmias

Background:

• Hyperkalemia is known to affect cardiac electrophysiology and can provoke arrhythmias.
• The anti-arrhythmic potential of hypercalcemia in the context of hyperkalemia-induced arrhythmias requires further investigation.

Purpose of the Study:

• To investigate the pro-arrhythmic effects of hyperkalemia on ventricular electrophysiology.
• To evaluate the anti-arrhythmic efficacy of hypercalcemia during hyperkalemia in isolated mouse hearts.

Main Methods:

• Langendorff-perfused mouse hearts were subjected to normokalemia, hyperkalemia (6.3 mM K+), and subsequent hypercalcemia (2.2 mM Ca2+).
• Monophasic action potential recordings and programmed electrical stimulation were used to assess electrophysiological parameters and induce ventricular tachycardia (VT).
• Key parameters analyzed included action potential durations (APD), ventricular effective refractory periods (VERP), and activation latencies.

Main Results:

• Hyperkalemia significantly increased the incidence of VT and shortened epicardial action potential durations and VERPs.
• Hypercalcemia treatment during hyperkalemia reduced VT incidence to near-baseline levels.
• Hypercalcemia reversed VERP shortening, normalized VERP/latency ratios, and decreased critical intervals for reexcitation.

Conclusions:

• Hyperkalemia exerts pro-arrhythmic effects by altering ventricular electrophysiological properties, specifically shortening APDs and VERPs.
• Hypercalcemia demonstrates significant anti-arrhythmic effects during hyperkalemia by restoring VERP and improving electrophysiological stability.
• These findings highlight the potential of modulating calcium levels as a therapeutic strategy against hyperkalemia-induced arrhythmias.